HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Christopher T Harbison Selected Research
Christopher T Harbison Research Topics
Disease
10
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2019 - 02/2010
10
Neoplasms (Cancer)
10/2019 - 08/2007
4
Colorectal Neoplasms (Colorectal Cancer)
06/2013 - 08/2007
2
Melanoma (Melanoma, Malignant)
10/2019 - 12/2014
2
Disease Progression
07/2016 - 07/2015
2
Body Weight (Weight, Body)
10/2015 - 07/2015
1
Renal Cell Carcinoma (Grawitz Tumor)
10/2019
1
Glioblastoma (Glioblastoma Multiforme)
01/2018
1
Renal Insufficiency (Renal Failure)
07/2016
1
Myasthenia Gravis
07/2016
1
Pneumonia (Pneumonitis)
07/2016
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
07/2016
1
Breast Neoplasms (Breast Cancer)
11/2010
1
Pleural Effusion (Pleural Effusions)
02/2010
Drug/Important Bio-Agent (IBA)
9
Nivolumab
IBA
10/2019 - 03/2015
4
Ipilimumab
IBA
10/2018 - 12/2014
4
Immune Checkpoint Inhibitors
IBA
01/2016 - 12/2014
4
Cetuximab (Erbitux)
FDA Link
06/2013 - 08/2007
3
Platinum
IBA
07/2016 - 10/2015
3
Docetaxel (Taxotere)
FDA Link
01/2016 - 07/2015
3
Ligands
IBA
01/2016 - 08/2007
2
Biomarkers (Surrogate Marker)
IBA
03/2011 - 02/2010
2
ErbB Receptors (EGF Receptor)
IBA
11/2010 - 02/2010
1
Monoclonal Antibodies
IBA
10/2019
1
B7-H1 Antigen
IBA
10/2018
1
Immunoglobulins (Immunoglobulin)
IBA
01/2016
1
Immunoglobulin G (IgG)
IBA
03/2015
1
Antibodies
IBA
12/2014
1
tremelimumab
IBA
12/2014
1
Codon (Codons)
IBA
06/2013
1
DNA (Deoxyribonucleic Acid)
IBA
06/2013
1
BMS-690514
IBA
05/2013
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
05/2013
1
Epidermal Growth Factor (EGF)
IBA
11/2010
1
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
11/2010
1
taxane
IBA
02/2010
1
Carboplatin (JM8)
FDA Link
Generic
02/2010
1
Epiregulin
IBA
08/2007
1
Growth Factor Receptors
IBA
08/2007
1
Amphiregulin
IBA
08/2007
Therapy/Procedure
6
Drug Therapy (Chemotherapy)
10/2018 - 02/2010
1
Therapeutics
10/2018
1
Immunotherapy
01/2018